Global Retirement Partners LLC lowered its position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 93.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 665 shares of the company’s stock after selling 9,974 shares during the period. Global Retirement Partners LLC’s holdings in DocuSign were worth $42,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in the business. MetLife Investment Management LLC acquired a new stake in shares of DocuSign during the first quarter worth about $1,337,000. Raymond James Trust N.A. raised its holdings in DocuSign by 27.3% during the 1st quarter. Raymond James Trust N.A. now owns 4,206 shares of the company’s stock worth $450,000 after buying an additional 901 shares during the period. Sei Investments Co. increased its position in shares of DocuSign by 21.8% during the first quarter. Sei Investments Co. now owns 177,214 shares of the company’s stock worth $18,934,000 after acquiring an additional 31,769 shares in the last quarter. National Pension Service lifted its position in DocuSign by 25.9% in the 1st quarter. National Pension Service now owns 347,633 shares of the company’s stock valued at $37,238,000 after acquiring an additional 71,449 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in shares of DocuSign by 20.3% in the 1st quarter. Vanguard Group Inc. now owns 17,308,877 shares of the company’s stock valued at $1,854,127,000 after purchasing an additional 2,917,683 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.
DocuSign Trading Up 0.3 %
DOCU opened at $59.66 on Tuesday. The stock’s fifty day simple moving average is $55.41 and its 200 day simple moving average is $51.22. DocuSign, Inc. has a 1-year low of $38.11 and a 1-year high of $64.76. The stock has a market cap of $12.25 billion, a PE ratio of 165.73, a price-to-earnings-growth ratio of 5.20 and a beta of 0.89.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on DOCU. Wells Fargo & Company reduced their price target on DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research report on Monday, February 5th. Morgan Stanley upgraded shares of DocuSign from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $49.00 to $64.00 in a research note on Tuesday, January 16th. JMP Securities reaffirmed a “market outperform” rating and issued a $84.00 target price on shares of DocuSign in a research report on Monday, January 22nd. Royal Bank of Canada reissued a “sector perform” rating and set a $50.00 price target on shares of DocuSign in a research report on Friday, January 12th. Finally, TheStreet raised DocuSign from a “d+” rating to a “c-” rating in a research report on Tuesday, December 19th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, DocuSign has an average rating of “Hold” and an average target price of $58.33.
View Our Latest Analysis on DocuSign
Insider Buying and Selling at DocuSign
In other news, insider James P. Shaughnessy sold 1,800 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $57.50, for a total transaction of $103,500.00. Following the completion of the sale, the insider now owns 46,503 shares in the company, valued at $2,673,922.50. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, CEO Allan C. Thygesen sold 7,680 shares of the firm’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the transaction, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider James P. Shaughnessy sold 1,800 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $57.50, for a total transaction of $103,500.00. Following the completion of the sale, the insider now directly owns 46,503 shares of the company’s stock, valued at approximately $2,673,922.50. The disclosure for this sale can be found here. Insiders have sold a total of 39,871 shares of company stock valued at $2,276,199 in the last three months. 17.80% of the stock is currently owned by company insiders.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than DocuSign
- Canada Bond Market Holiday: How to Invest and Trade
- Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
- 3 Stocks to Consider Buying in October
- The 5 Hottest CEO Stock Purchases So Far This Year
- The 3 Best Retail Stocks to Shop for in August
- Institutions Think This Consumer Stock Could Break Higher
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.